Artery stiffness may predict Type 2 diabetes risk better than BP and standard risk factors: American Heart Association
2022 JUN 01 (NewsRx) -- By a
According to the
“Identification of individuals at high risk of developing Type 2 diabetes is of utmost importance since early intervention can help prevent the onset and slow the progress of the condition,” said Anxin Wang, Ph.D., senior study author and a researcher at the
Previous studies have found that hypertension, or high blood pressure, is a risk factor for Type 2 diabetes. Arterial stiffness, a common finding in people with high blood pressure, is also associated with insulin resistance and Type 2 diabetes.
“Since people with either hypertension or arterial stiffness tend to have a higher risk of developing Type 2 diabetes, we investigated which of these factors may be more effective in predicting an individual’s future risk of Type 2 diabetes,” Wang said.
Researchers examined health data from 11,156 participants of the
In this study, participants were defined as having hypertension if their resting blood pressure was 140 mm Hg/90 mm Hg or greater, which is in line with both the 2018 Chinese Guidelines for Prevention and Treatment of Hypertension and the
The researchers defined patients as having Type 2 diabetes based on either measuring a fasting blood sugar level of 7.0 mmol/L, or they self-reported a physician diagnosis reported taking antidiabetic medications.
By 2017, six years after the cohort began being tracked, approximately 7% of the study participants had developed Type 2 diabetes. The analysis compared the risk of Type 2 diabetes among people with: 1) ideal vascular function, defined as normal blood pressure and arteries that exhibited normal amounts of stiffness; 2) normal blood pressure with stiffer arteries; 3) high blood pressure and normal arteries; and 4) high blood pressure with stiffer arteries.
The analysis found that:
“We were surprised to find that people with increased arterial stiffness were more likely to develop Type 2 diabetes, whether they had high blood pressure or not,” Wang said. “These results provide strong evidence that measuring arterial stiffness may be a better predictor than blood pressure in determining an individual’s future risk of Type 2 diabetes.”
The analysis also found that the combination of high blood pressure and stiffer arteries was more likely in men, and among people who were older, had a higher BMI (body mass index, which is a measure of body weight in proportion to height) and higher heart rate and reported smoking cigarettes and drinking alcohol. People with increased arterial stiffness also had higher fasting blood glucose and cholesterol levels compared to participants who did not. Additionally, the researchers found that adjusting the analysis to consider BMI did not change the association between arterial stiffness and Type 2 diabetes.
“These findings provide new insight into the prevention of Type 2 diabetes, indicating that early detection and treatment for high blood pressure and arterial stiffness may help reduce the risk of developing Type 2 diabetes,” Wang added.
Wang adds that more studies are needed to further investigate the underlying mechanisms involved in the associations for arterial stiffness, high blood pressure and Type 2 diabetes risk and to determine the optimal range of arterial thickness and blood pressure for preventing Type 2 diabetes.
According to the
“This finding that arterial stiffness increases the risk for developing Type 2 diabetes supports our existing understanding of cardiovascular disease and Type 2 diabetes,” said
Co-authors are
This study was supported by the
Studies published in the American Heart Association’s scientific journals are peer-reviewed. The statements and conclusions in each manuscript are solely those of the study authors and do not necessarily reflect the Association’s policy or position. The Association makes no representation or guarantee as to their accuracy or reliability. The Association receives funding primarily from individuals; foundations and corporations (including pharmaceutical, device manufacturers and other companies) also make donations and fund specific Association programs and events. The Association has strict policies to prevent these relationships from influencing the science content. Revenues from pharmaceutical and biotech companies, device manufacturers and health insurance providers and the Association’s overall financial information are available here.
Additional Resources:
Keywords for this news article include:
(Our reports deliver fact-based news of research and discoveries from around the world.)
Patent Issued for Strong authentication via distributed stations (USPTO 11328799): Imprivata Inc.
DeSantis signs insurance bill
Advisor News
Annuity News
Health/Employee Benefits News
Life Insurance News